Teleflex Incorporated (NYSE:TFX – Get Free Report) reached a new 52-week high on Wednesday. The stock traded as high as $162.41 and last traded at $161.3690, with a volume of 24,810 shares changing hands. The stock had previously closed at $159.55.
Analysts Set New Price Targets
A number of analysts have recently issued reports on TFX shares. Bank of America raised Teleflex from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $145.00 to $158.00 in a research note on Monday, September 28th. Truist Financial increased their price objective on Teleflex from $142.00 to $167.00 and gave the company a “hold” rating in a research note on Monday, November 9th. Wall Street Zen upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Saturday, November 7th. Needham & Company LLC lifted their target price on shares of Teleflex from $159.00 to $170.00 and gave the stock a “buy” rating in a research note on Tuesday, August 25th. Finally, Mizuho set a $160.00 target price on shares of Teleflex in a research note on Friday, November 6th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $163.30.
Teleflex Trading Up 2.5%
The firm has a market capitalization of $6.49 billion, a price-to-earnings ratio of 19.88, a PEG ratio of 1.05 and a beta of 0.85. The company has a fifty day moving average price of $134.43 and a two-hundred day moving average price of $127.90. The company has a current ratio of 2.01, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.
Teleflex (NYSE:TFX – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The medical technology company reported $2.63 EPS for the quarter, beating the consensus estimate of $1.90 by $0.73. Teleflex had a return on equity of 10.57% and a net margin of 13.51%. The firm had revenue of $567.80 million during the quarter, compared to analysts’ expectations of $565.52 million. During the same quarter last year, the firm earned $3.67 earnings per share. The business’s revenue for the quarter was up .1% on a year-over-year basis. As a group, research analysts forecast that Teleflex Incorporated will post 7.67 earnings per share for the current fiscal year.
Teleflex Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, December 31st. Shareholders of record on Monday, November 16th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.8%. The ex-dividend date is Monday, November 16th. Teleflex’s dividend payout ratio is presently 16.52%.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. BlackRock Inc. purchased a new stake in shares of Teleflex in the second quarter valued at about $688,537,000. Jupiter Topco LLC acquired a new stake in Teleflex during the second quarter worth about $550,456,000. Janus Henderson Group PLC increased its position in Teleflex by 1.1% during the first quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company’s stock worth $513,281,000 after purchasing an additional 45,199 shares during the last quarter. Irenic Capital Management LP purchased a new position in Teleflex during the first quarter worth about $104,061,000. Finally, Pzena Investment Management LLC purchased a new position in Teleflex during the second quarter worth about $76,462,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.
About Teleflex
Teleflex is a global medical technology company that develops, manufactures and markets single-use medical devices used by healthcare professionals in hospitals and other care settings. Its products support a range of procedures, including vascular access, anesthesia, critical care, surgery, urology and emergency medicine. The company’s offerings include vascular and interventional access devices, catheters, airway management products, surgical instruments and other devices used in diagnostic and therapeutic procedures.
Further Reading
- Five stocks we like better than Teleflex
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
- SpaceX’s Historic Starship Catch Raises a Bigger Question About Its AI Spending
- AMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?
- 3 Stocks Flashing Buy Signals With Historical Win Rates Above 85% After the Sell-Off
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
